Literature DB >> 29619925

The validity of the diagnosis of heart failure (I50.0-I50.9) in the Danish National Patient Register.

Joanna Delekta1, Steen Møller Hansen, Karam Sadoon AlZuhairi, Christian Sørensen Bork, Albert Marni Joensen.   

Abstract

INTRODUCTION: National discharge registers are important and cost-effective data sources for administrative and research purposes, but their value depends much on the validity of the registered data. The objective of this study was to assess the validity of heart failure (HF) diagnoses (ICD10: I50.0-I50.9) in the Danish National Patient Register (DNPR).
METHODS: We reviewed medical records from a random sample of 500 patients with either a primary or a secondary discharge diagnosis of HF registered in the DNPR from any department in Northern Denmark in 2007. We noted symptoms, objective signs, diagnostic imaging and biomarkers and used the European Society of Cardiology definition of HF to categorise patients into definite, probable or non-
verified HF.
RESULTS: We classified 305 patients as having definite HF and 113 patients as having probable HF. The remaining cases were classified as non-verified HF. Thus, the positive predictive value (PPV) for definite and probable HF was 83.6% (95% confidence interval (CI): 80.1-86.7%).
The PPV increased to 88.0% (95% CI: 84.4-91.0%) when we restricted analyses to primary diagnoses and to 95.2% (95% CI: 89.2-98.4%) when we restricted analyses to HF diagnoses established at cardiology units.
CONCLUSIONS: The HF diagnoses (I50.0-I50.9) in the DNPR should be used with caution if validation is not possible. However, restricting analyses to patients registered with a primary diagnosis of HF or patients discharged from cardiology units may be a useful alternative in population-based studies. FUNDING: none. TRIAL REGISTRATION: not relevant. Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Year:  2018        PMID: 29619925

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  12 in total

1.  On the search for the right definition of heart failure with preserved ejection fraction.

Authors:  Agnieszka Kapłon-Cieślicka; Karolina Kupczyńska; Piotr Dobrowolski; Błażej Michalski; Miłosz J Jaguszewski; Waldemar Banasiak; Paweł Burchardt; Łukasz Chrzanowski; Szymon Darocha; Justyna Domienik-Karłowicz; Jarosław Drożdż; Marcin Fijałkowski; Krzysztof J Filipiak; Marcin Gruchała; Ewa A Jankowska; Piotr Jankowski; Jarosław D Kasprzak; Wojciech Kosmala; Piotr Lipiec; Przemysław Mitkowski; Katarzyna Mizia-Stec; Piotr Szymański; Agnieszka Tycińska; Wojciech Wańha; Maciej Wybraniec; Adam Witkowski; Piotr Ponikowski; On Behalf Of "Club 30" Of The Polish Cardiac Society
Journal:  Cardiol J       Date:  2020-09-28       Impact factor: 2.737

2.  Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study.

Authors:  Abdulrahman N Shams-Eldin; Adelina Yafasova; Mikkel Faurschou; Morten Schou; Guoli Sun; Gunnar H Gislason; Christian Torp-Pedersen; Emil L Fosbøl; Lars Køber; Jawad H Butt
Journal:  Clin Rheumatol       Date:  2022-07-30       Impact factor: 3.650

3.  Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; R Nesvåg; L Balteskard; J G Bramness; C M Hultman; Ø Naess; T Reichborn-Kjennerud; E Ystrom; B K Jacobsen; A Høye
Journal:  Acta Psychiatr Scand       Date:  2020-02-29       Impact factor: 6.392

4.  Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness.

Authors:  I H Heiberg; B K Jacobsen; L Balteskard; J G Bramness; Ø Naess; E Ystrom; T Reichborn-Kjennerud; C M Hultman; R Nesvåg; A Høye
Journal:  Acta Psychiatr Scand       Date:  2019-03-29       Impact factor: 6.392

5.  Do we need a definition of acute heart failure with preserved ejection fraction?

Authors:  Agnieszka Kapłon-Cieślicka; Lars H Lund
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

6.  Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard.

Authors:  Camilla Rye; Katrine Hass Rubin; Frederik Trier Moller; Mette Julsgaard; Tine Jess; Vibeke Andersen
Journal:  Clin Epidemiol       Date:  2021-05-24       Impact factor: 4.790

7.  Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?

Authors:  Morten Malmborg; Michelle D S Schmiegelow; Caroline H Nørgaard; Anders Munch; Thomas Gerds; Morten Schou; Caroline Kistorp; Christian Torp-Pedersen; Mark A Hlatky; Gunnar Gislason
Journal:  Eur Heart J       Date:  2020-04-01       Impact factor: 29.983

8.  Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment.

Authors:  Annette de Thurah; Ina Trolle Andersen; Andreas Bugge Tinggaard; Anders Hammerich Riis; Josephine Therkildsen; Hans Erik Bøtker; Morthen Bøttcher; Ellen-Margrethe Hauge
Journal:  RMD Open       Date:  2020-01

Review 9.  Validity of Acute Cardiovascular Outcome Diagnoses Recorded in European Electronic Health Records: A Systematic Review.

Authors:  Jennifer Davidson; Amitava Banerjee; Rutendo Muzambi; Liam Smeeth; Charlotte Warren-Gash
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

10.  Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium.

Authors:  Matti A Vuori; Jaakko Reinikainen; Stefan Söderberg; Ellinor Bergdahl; Pekka Jousilahti; Hugh Tunstall-Pedoe; Tanja Zeller; Dirk Westermann; Susana Sans; Allan Linneberg; Licia Iacoviello; Simona Costanzo; Veikko Salomaa; Stefan Blankenberg; Kari Kuulasmaa; Teemu J Niiranen
Journal:  Cardiovasc Diabetol       Date:  2021-09-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.